
In this program, Sagar Lonial, MD, a nationally recognized expert in multiple myeloma, guides participants through a series of clinical questions centered around four patient cases. These cases serve as a framework for exploring risk stratification, treatment selection, and adverse effect management in patients with multiple myeloma. Faculty member, Dr. Lonial, provides responses to these clinical questions, offering valuable insights and evidence-based recommendations. Dr. Lonial's extensive research and clinical experience in the field enable him to share best practices and clinical pearls for managing relapsed/refractory multiple myeloma in adults. The program format fosters interactive discussions, allowing participants to engage with the patient cases and benefit from the expertise of the faculty.
Course Credit:
1 AMA PRA Category 1 CreditTM
1 ANCC Contact Hour
1 Pharmacology Hour
Dates:
Opens: 2023-05-25
Closes: 2024-05-25
Target Audience:
This activity is intended for hematologist-oncologists, advanced practitioners, oncology nurses, pharmacists, and other healthcare professionals involved in the care of patients diagnosed with multiple myeloma.
This activity is supported by educational grants from Sanofi and Karyopharm.
Accreditation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1 contact hour, including 1 pharmacology hour.
Additional Content Planners
James Davis, PharmD, BCOP (Medical Writer)No significant relationships to disclose.
Heather Jimenez, MSN, FNP-C (Nurse Planner)
No significant relationships to disclose.
Kam A. Newman, MD (Peer Reviewer)
No significant relationships to disclose.
Annenberg Center for Health Sciences
Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant financial relationships to disclose.
All of the financial relationships listed for these individuals have been mitigated.
-
Sagar Lonial, MD, FACP
Chair and Professor
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia
Presenting Faculty
Downloads
Learning Objectives
- Illustrate the use of risk stratification in treatment selection for front-line multiple myeloma
- Implement treatment strategies for patients with early-relapse multiple myeloma
- Evaluate current guidelines and emerging clinical data for relapsed/refractory multiple myeloma
- Identify appropriate management strategies for adverse effects associated with novel-targeted therapies
Faculty Disclosures
Sagar Lonial, MD, FACP
Advisory Board: AbbVie, Amgen, BMS, Genentech, Janssen, Novartis, Pfizer, Takeda
Board of Directors: TG Therapeutics